You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

List of Excipients in API ritlecitinib

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing ritlecitinib

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Pfizer Laboratories Div Pfizer Inc	LITFULO	ritlecitinib	0069-0334	CELLULOSE, MICROCRYSTALLINE	2028-06-23
Pfizer Laboratories Div Pfizer Inc	LITFULO	ritlecitinib	0069-0334	CROSPOVIDONE	2028-06-23
Pfizer Laboratories Div Pfizer Inc	LITFULO	ritlecitinib	0069-0334	FD&C BLUE NO. 1	2028-06-23
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for ritlecitinib

Excipient focus: CELLULOSE, MICROCRYSTALLINE

ritlecitinib drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	ritlecitinib	0069-0334
US Pharmaceuticals	ritlecitinib	63539-334
>Company	>Ingredient	>NDC

ritlecitinib drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSPOVIDONE

ritlecitinib drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	ritlecitinib	0069-0334
US Pharmaceuticals	ritlecitinib	63539-334
>Company	>Ingredient	>NDC

ritlecitinib drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FD&C BLUE NO. 1

ritlecitinib drug variants containing FD&C BLUE NO. 1

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	ritlecitinib	0069-0334
US Pharmaceuticals	ritlecitinib	63539-334
>Company	>Ingredient	>NDC

ritlecitinib drug variants not containing FD&C BLUE NO. 1

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

ritlecitinib drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	ritlecitinib	0069-0334
US Pharmaceuticals	ritlecitinib	63539-334
>Company	>Ingredient	>NDC

ritlecitinib drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GLYCERYL DIBEHENATE

ritlecitinib drug variants containing GLYCERYL DIBEHENATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	ritlecitinib	0069-0334
US Pharmaceuticals	ritlecitinib	63539-334
>Company	>Ingredient	>NDC

ritlecitinib drug variants not containing GLYCERYL DIBEHENATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

ritlecitinib drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	ritlecitinib	0069-0334
US Pharmaceuticals	ritlecitinib	63539-334
>Company	>Ingredient	>NDC

ritlecitinib drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

ritlecitinib drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	ritlecitinib	0069-0334
US Pharmaceuticals	ritlecitinib	63539-334
>Company	>Ingredient	>NDC

ritlecitinib drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

ritlecitinib drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	ritlecitinib	0069-0334
US Pharmaceuticals	ritlecitinib	63539-334
>Company	>Ingredient	>NDC

ritlecitinib drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.